SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-K - Annual report [Section 13 and 15(d), not S-K Item 405]:
SEC Accession No. 0001193125-23-077859
Filing Date
2023-03-23
Accepted
2023-03-23 16:06:32
Documents
78
Period of Report
2022-12-31

Document Format Files

Seq Description Document Type Size
1 10-K d446975d10k.htm   iXBRL 10-K 1740841
2 EX-10.12 d446975dex1012.htm EX-10.12 390927
3 EX-21.1 d446975dex211.htm EX-21.1 2903
4 EX-23.1 d446975dex231.htm EX-23.1 3410
5 EX-31.1 d446975dex311.htm EX-31.1 10404
6 EX-31.2 d446975dex312.htm EX-31.2 10469
7 EX-32.1 d446975dex321.htm EX-32.1 5160
13 GRAPHIC g446975g00g01.jpg GRAPHIC 585839
  Complete submission text file 0001193125-23-077859.txt   9970094

Data Files

Seq Description Document Type Size
8 XBRL TAXONOMY EXTENSION SCHEMA cbay-20221231.xsd EX-101.SCH 56604
9 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE cbay-20221231_cal.xml EX-101.CAL 41938
10 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE cbay-20221231_def.xml EX-101.DEF 268597
11 XBRL TAXONOMY EXTENSION LABEL LINKBASE cbay-20221231_lab.xml EX-101.LAB 464034
12 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE cbay-20221231_pre.xml EX-101.PRE 379509
72 EXTRACTED XBRL INSTANCE DOCUMENT d446975d10k_htm.xml XML 1510161
Mailing Address 7575 GATEWAY BOULEVARD SUITE 110 NEWARK CA 94560
Business Address 7575 GATEWAY BOULEVARD SUITE 110 NEWARK CA 94560 510-293-8800
CymaBay Therapeutics, Inc. (Filer) CIK: 0001042074 (see all company filings)

IRS No.: 943103561 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-K | Act: 34 | File No.: 001-36500 | Film No.: 23756240
SIC: 2834 Pharmaceutical Preparations